Bausch Health Cos (BHC) Insider Trading & Ownership $6.83 +0.05 (+0.74%) Closing price 03:59 PM EasternExtended Trading$6.96 +0.13 (+1.83%) As of 07:03 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Bausch Health Cos (NYSE:BHC) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage19.97%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$369.63MNumber OfInsiders Selling(Last 12 Months)0 Get BHC Insider Trade Alerts Want to know when executives and insiders are buying or selling Bausch Health Cos stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BHC Insider Buying and Selling by Quarter Bausch Health Cos Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/14/2025John PaulsonDirectorBuy34,721,118$9.00$312,490,062.00 8/13/2025John PaulsonDirectorBuy86,409$7.06$610,047.54 8/12/2025John PaulsonDirectorBuy1,156,640$6.88$7,957,683.20 8/11/2025John PaulsonDirectorBuy2,000,000$6.35$12,700,000.00 6/13/2025John PaulsonDirectorBuy3,564,059$5.94$21,170,510.46 6/12/2025John PaulsonDirectorBuy1,005,376$5.47$5,499,406.72 6/11/2025John PaulsonDirectorBuy1,029,098$5.24$5,392,473.52 6/10/2025John PaulsonDirectorBuy754,134$5.05$3,808,376.70 (Data available from 1/1/2013 forward) BHC Insider Trading Activity - Frequently Asked Questions Who is on Bausch Health Cos' Insider Roster? The list of insiders at Bausch Health Cos includes John Paulson, and Seana Carson. Learn more on insiders at BHC. What percentage of Bausch Health Cos stock is owned by insiders? 19.97% of Bausch Health Cos stock is owned by insiders. Learn more on BHC's insider holdings. Which Bausch Health Cos insiders have been buying company stock? The following insider purchased BHC shares in the last 24 months: John Paulson ($369,628,560.14). How much insider buying is happening at Bausch Health Cos? Insiders have purchased a total of 44,316,834 BHC shares in the last 24 months for a total of $369,628,560.14 bought. Which Bausch Health Cos insiders have been selling company stock? The following insider sold BHC shares in the last 24 months: Seana Carson ($84,978.53). How much insider selling is happening at Bausch Health Cos? Insiders have sold a total of 13,633 Bausch Health Cos shares in the last 24 months for a total of $84,978.53 sold. Bausch Health Cos Key ExecutivesMr. Thomas J. Appio (Age 62)CEO & Director Compensation: $2.74MMr. John S. Barresi (Age 51)Senior VP, Controller, Chief Accounting Officer & Interim CFO Compensation: $796.8kMs. Seana Carson (Age 51)Executive VP & General Counsel Compensation: $872.65kMr. Mirza DautbegovicSenior VP & COOMr. Josh CoyleSenior Vice President of Sales & SalixMs. Kathleen FitzpatrickSenior VP & Chief HR OfficerDr. Tage Ramakrishna M.D. (Age 50)Chief Medical Officer and President of R&D Mr. Jeff HartnessExecutive VP of Market Access, Commercial Operations, Neurology, Generics & Government AffairsDr. Graham JacksonSenior VP & Chief Quality OfficerMr. Cees HeimanSenior Vice President of Europe & Canada More Insider Trading Tools from MarketBeat Related Companies BridgeBio Pharma Insider Trades Roivant Sciences Insider Trades Elanco Animal Health Insider Trades Verona Pharma PLC American Depositary Share Insider Trades Moderna Insider Trades Revolution Medicines Insider Trades Grifols Insider Trades Rhythm Pharmaceuticals Insider Trades Cytokinetics Insider Trades Axsome Therapeutics Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles $100 Million Buyback in Upwork Stock Follows a Strong Quarter Insiders Sell These High-Quality Stocks: Why Investors Shouldn’tCoreWeave and Madrigal's Insider Trades Flash Bullish SignalsPalantir Insider Selling: Risk Signal or Normal Activity?Loop Industries Insiders Buy Stock, Signal Confidence in Outlook This page (NYSE:BHC) was last updated on 9/17/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bausch Health Cos Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bausch Health Cos With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.